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Primary cutaneous diffuse large B-cell lymphoma, leg type mimicking cellulitisDear Editor,
The skin is the second most common site of primary extranodal
non-Hodgkin lymphoma following the gastrointestinal tract. The
2005 World Health Organization-European Organization for
Research and Treatment of Cancer (WHO-EORTC) scheme recog-
nizes 3 types of primary cutaneous B-cell lymphomas: primary
cutaneous marginal zone B-cell lymphoma, primary cutaneous
follicular center cell lymphoma, and primary cutaneous diffuse
large B-cell lymphoma (DLBCL), leg type (PCLBCL-leg), with the
last one carrying the worst prognosis.1 PCLBCL-leg most commonly
arises in the leg and constitutes 4% of primary cutaneous
lymphomas and 20% of primary cutaneous B-cell lymphomas.2
These lymphomas preferentially affect elder women and usually
present with rapidly growing red or bluish-red cutaneous nodules
or tumors on one or both lower legs. The large transformed B-cells
extend into the subcutaneous tissue and often disseminate to
extracutaneous sites. PCLBCL-leg shows an inferior prognosis as
compared to those presenting at other anatomical sites.3
Cellulitis is an inﬂammatory disorder of the skin and subcuta-
neous tissue, and is most commonly caused by an infectious agent.
Non-infectious causes such as malignant neoplasms may
masquerade as infectious cellulitis and lead to a delayed diagnosis.4
To date, there are only a few single-case reports of lymphoma
masquerading as cellulitis.5–7 Here we present the ﬁrst case of
PCLBCL-leg masquerading as cellulitis. Our case underscores the
importance of physicians in recognizing those patients with a clin-
ical diagnosis of cellulitis but not responding to antimicrobial
treatment.
A 72-year-old woman presenting with reddish discoloration,
swelling and pain over her left lower leg for a week had been
unsuccessfully treated with antibiotics following a diagnosis of
cellulitis. Physical examination revealed erythema, swelling, and
local heat with focal induration (Figure 1A and B). There was no
lymphadenopathy. The patient’s performance status score was 1.
Her serum lactate dehydrogenase level was elevated, while her
C-reactive protein and hemogram were normal including white
blood cell count at 4630/mL. Blood cultures showed no growth.
Sonography was compatible with cellulitis without abscess
formation.
After admission, the patient continued to receive antibiotic
treatment for 10 days, during which the swelling subsided but
the induration and local heat persisted. Cutaneous biopsy showed
a dense and diffuse lymphocytic inﬁltration in the dermis
(Figure 1C). The lymphocytes were medium-to-large sized with1027-8117/$ – see front matter Copyright  2012, Taiwanese Dermatological Associatio
http://dx.doi.org/10.1016/j.dsi.2012.10.006frequent mitosis (Figure 1D) expressing CD20 (Figure 1D inset),
bcl-2, bcl-6 and IRF4/MUM1 with a proliferation index of 90%.
They were negative for CD3, CD10, CD34, terminal deoxynucleo-
tidyl transferase or cyclin D1. The patient was diagnosed as having
PCLBCL-leg with a non-germinal center phenotype according to
the Hans algorithm.8 Staging workup including bone marrow
biopsy revealed stage IE disease and an international prognostic
index score of 2. She received cyclophosphamide, doxorubicin,
vincristine and prednisolone plus rituximab (R-CHOP) and
achieved a dramatic response, with complete remission after six
courses of treatment.
Unfortunately a relapsed nodule, 5  5  2 cm in size without
features of cellulitis appeared 15 months later in her left forearm.
Biopsy of the recurrent tumor showed the same histological
features as the initial specimen. She received salvage chemotherapy
but passed away 23 months after initial diagnosis due to disease
progression.
PCLBCL-leg usually presents as rapidly-developing multiple red
or bluish-red nodules.2 In a series of 50 cases, 88% patients initially
presented with cutaneous nodule/tumor, 6% with plaque, 4% with
large subcutaneous tumor, and 2% with ulceration.9 None of the
patients presented with features of cellulitis.
Infectious agents cause most cases of cellulitis. For cellulitis that
does not respond to antimicrobial treatment, clinicians should
consider several noninfectious disorders.4 The most common
causes include thrombophlebitis, contact dermatitis, insect stings,
drug reactions, eosinophilic cellulitis (Wells syndrome), gouty
arthritis, carcinoma erysipelatoides, familial Mediterranean fever,
and foreign-body reactions.4 The less common causes are urticaria,
lymphedema, lupus erythematosus, sarcoidosis, lymphoma,
leukemia, Paget’s disease, and panniculitis.4 Rare cases of
lymphoma, such as primary DLBCL of the skeletal muscle, orbital
plasmablastic lymphoma and DLBCL, subcutaneous panniculitis-
like T-cell lymphoma, extranodal peripheral T-cell lymphoma,
and extranodal natural killer/T-cell lymphoma, may masquerade
as infectious cellulitis.5–7
PCLBCL-leg is a recently-deﬁned subtype of DLBCL and is
composed exclusively of large transformed B-cells occurring most
commonly (in around 70% cases), but not exclusively, on the
legs.2,9 Other entities such as primary cutaneous follicle center
lymphoma, primary cutaneous T-cell-rich large B-cell lymphoma
and intravascular large B-cell lymphoma (IVLBCL) should be
excluded. IVLBCL is a rare type of DLBCL with neoplastic cells pref-
erentially growingwithin the vascular lumens and is usually widely
disseminated in extranodal sites, most commonly in the centraln. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A and B) The left lower leg skin shows geographic and anastomosing erythema with an erythematous induration on the posterior aspect. (C) The low-power photomi-
crograph shows diffuse dermal inﬁltration with sparing of the epidermis (hematoxylin and eosin stain; original magniﬁcation, 20). (D) High power view reveals large tumor cells
with vesicular nuclei (hematoxylin and eosin stain; original magniﬁcation, 400). The inset shows tumor cells expressing CD20 while the sweat gland in the left is negative (CD20
stain; original magniﬁcation, 400). The tumor has a B-cell, non-germinal center phenotype.
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a widespread morphology and distribution, including painful indu-
rate erythematous eruption, poorly circumscribed violaceous pla-
ques, swelling overlying skin ‘peau d’orange’, cellulitis, large
solitary plaques, painful blue-red palpable nodular discolorations,
tumor, ulcerated nodules, small red palpable spots, and erythema-
tous and desquamative plaques.10 Patients with disease limited to
the skin were predominantly females with a better prognosis.
Our case is distinct from IVLBCL by a diffuse inﬁltration of large
neoplastic B-cells in the dermis without a preferential growth in
the vascular lumens. The reason for the erythematous change of
our patient’s cutaneous lesions was unclear. It might be due to
vascular involvement as well, which could not be conﬁrmed in
the small biopsy.
The prognosis of patients with PCLBCL-leg is poor, with a 5-year
survival of 50%.2 Treatment modalities include radiotherapy, single
and multi-agent chemotherapy, chemoradiotherapy, and rituximab
as single agent or in combination with chemotherapy agents.2,9 R-
CHOP with or without radiotherapy is recommended by the Euro-
pean Organisation for Research and Treatment of Cancer Cutaneous
Lymphoma Group and the International Society for Cutaneous
Lymphomas as ﬁrst-line treatment.11 The efﬁcacy of this approach
in patients with PCLBCL-leg is still poorly documented, however,
because no systematic reviews or randomized-controlled trials
are available, and these recommendations are mainly based on
retrospective studies and small cohort studies.11 Whether radio-
therapy should be considered the ﬁrst choice of treatment in
patients presenting with a small solitary tumor is a matter of
debate. Our patient was treated with the internationally recom-
mended regimen (R-CHOP) and obtained complete remission for
1 year; unfortunately, the disease relapsed at the other cutaneous
site, reﬂecting the aggressive behavior of this lymphoma type.9
In conclusion, we present a rare case of PCLBCL-leg with clinical
features of cellulitis. Diagnosis of lymphomas masquerading as
cellulitis is challenging for physicians. Our case underscores the
importance of searching for possible underlying causes in patientswith a clinical diagnosis of cellulitis that does not respond to
antibiotics.
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